ShiraTronics (migraine treatment device)

2024: Product Announcement

On February 6, 2024, the American medical device developer ShiraTronics introduced an implantable migraine treatment device in the head. The system uses neurostimulation technology to eliminate the debilitating symptoms of this ailment.

Migraines most often begin during puberty, and the disease causes the greatest suffering for people aged 35-45 years. Moreover, women suffer from migraine about twice as often as men, which is explained by hormonal factors. Symptoms include headaches that increase with physical activity/movement, visual impairment, increased sensitivity to light, sound and odors, nausea, dizziness, etc. Migraines often lead to disability. Existing treatments often fall short of expectations: In this case, a decision by ShiraTronics can come to the rescue.

𝓲

ShiraTronics

The device is implanted in the head through a minimally invasive procedure. It provides targeted electrical pulses designed to suppress pain signals. As a result, a significant improvement in the well-being of patients is achieved, which increases their quality of life.

ShiraTronics states that the data obtained from the study showed promising results, indicating a significant decrease in the number of migraine days in patients after four weeks of therapy. The company also reported a marked decrease in headache duration and severity. People who have received a new type of therapy have an improvement in their overall condition.

When drugs do not reduce the frequency and/or severity of chronic migraine attacks, neurostimulation may be an effective solution. Our device is placed under the skin and acts on target nerves to relieve migraine symptoms, notes ShiraTronics.[1]

Notes